| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/02/2006 | WO2004066933A3 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 03/02/2006 | US20060046971 Treatment of transformed or infected biological cells |
| 03/02/2006 | US20060046255 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/02/2006 | US20060046250 Novel use of aim 3 acting as a tumor suppressor |
| 03/02/2006 | US20060046248 RNA interference in avians |
| 03/02/2006 | US20060046247 Protecting avians from pathogens |
| 03/02/2006 | US20060045878 Pancreas-derived plasminogen activator inhibitor |
| 03/02/2006 | US20060045874 Such as Hurler syndrome and Batten by administering an aminoglycosidesuch as gentamicin, G418, hygromycin B, paromomycin, tobramycin, lividomycin A, amikacin, sisomycin, or neomycin in combination with an enzyme effective for enzyme replacement therapy, a polyionic compound or gene therapy |
| 03/02/2006 | US20060045873 Induction of methylation of CpG sequences by dsRNAS in mammalian cells |
| 03/02/2006 | CA2578021A1 Modified human hepatitis c virus genomic rna that can be autonomously replicated |
| 03/02/2006 | CA2576462A1 Adeno-associated viral vector for exon skipping in a gene encoding a dispensable-domain protein |
| 03/02/2006 | CA2574463A1 Nanocoating for improving biocompatibility of medical implants |
| 03/01/2006 | EP1629848A1 Apoptosis inducing agent and method of inducing apoptosis |
| 03/01/2006 | EP1629106A2 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-beta-PROTEINS (TGF-betas) IN CELLS |
| 03/01/2006 | EP1629099A1 Compositions and methods for preventing and treating liver cirrhosis |
| 03/01/2006 | EP1629091A2 Compound containing polyprotein ns3/ns4 and hcv polypeptide ns5b, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof |
| 03/01/2006 | EP1629085A2 Transfection agents |
| 03/01/2006 | EP1629084A2 Modulation of c-reactive protein expression |
| 03/01/2006 | EP1629008A1 Tnf-like secreted protein |
| 03/01/2006 | EP1628993A2 Methods and compositions for rna interference |
| 03/01/2006 | EP1628992A2 Methods of modulating metastasis and skeletal related events resulting from metastases |
| 03/01/2006 | EP1628628A2 Methods of reducing an immune response |
| 03/01/2006 | EP1628624A2 Methods and compositions for interferon therapy |
| 03/01/2006 | EP1628535A2 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
| 03/01/2006 | EP1628531A2 Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents |
| 03/01/2006 | EP1542731A4 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 03/01/2006 | EP1351972B1 Lipids comprising an aminoxy group |
| 03/01/2006 | EP1311672B1 tRNA-derived inhibitors of HIV reverse transcriptase |
| 03/01/2006 | EP1305636B1 Screening method |
| 03/01/2006 | EP1290205B1 Duplexed parvovirus vectors |
| 03/01/2006 | EP1263475B1 Synthetic oligonucleotides as inducers of erythroid differentiation |
| 03/01/2006 | EP1244433B1 Use of non-human SHIP2 knock-out mammals |
| 03/01/2006 | EP1092035B1 Targeted integration into chromosomes using retroviral vectors |
| 03/01/2006 | EP1049488B1 Method of and compositions for immunization with the pseudomonas aeruginosa v-antigen |
| 03/01/2006 | EP1003556B1 Cationic reagents for transfection |
| 03/01/2006 | EP0932678B1 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 03/01/2006 | EP0907735B1 Modulators of tissue regeneration |
| 03/01/2006 | EP0862634B2 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 03/01/2006 | CN1741821A Compositions for cancer treatment |
| 03/01/2006 | CN1741820A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/01/2006 | CN1741817A A hepatitis c virus codon optimized non-structural NS3/4A fusion gene |
| 03/01/2006 | CN1741816A Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 03/01/2006 | CN1740326A Recombination chimeric molecule Cb1-Grb2(SH2)-RING eukaryotic expression plasmid and antitumor genetic medicine use |
| 03/01/2006 | CN1739805A Composition and method of diagnosing and treating type-II diabetes and sugar tolerance abnormality |
| 03/01/2006 | CN1243828C RNA adaptor capable of restraining typhoid bacilli from invading to cells of human body, and preparation method |
| 03/01/2006 | CN1243770C Neurotrophic growth factor |
| 02/28/2006 | US7005500 Nucleotide sequence coding polypeptide for use in the diagnosis of of neoplastic disorders |
| 02/28/2006 | US7005424 Admininstering mixtures of anticarcinogenic agents and early genes for prophylaxis of cancer, tumors or metastasis; gene expression inhibitors |
| 02/28/2006 | US7005285 Human p21-activated kinase 5 polypeptide |
| 02/28/2006 | US7005277 Defective adenoviruses and corresponding complementation lines |
| 02/28/2006 | US7005275 Inducible alphaviral gene expression system |
| 02/28/2006 | US7005262 Methods for detecting nucleic acids encoding human telomerase reverse transcriptase |
| 02/28/2006 | US7005140 composition that includes a charged lipid for interaction with a charged therapeutic agent, yet which bears minimal external surface charge after formation. |
| 02/28/2006 | US7005139 Drug delivery, pharmacology and cancer chemotherapy |
| 02/28/2006 | US7005127 Mixed-cell gene therapy |
| 02/28/2006 | US7005126 Administering near the tumor xenogeneic retroviral vector producer cells having alpha (1,3)galactosyl epitopes to activate a hyperacute rejection response; treatment is not followed with ganciclovir; ovarian tumors for example |
| 02/28/2006 | US7004945 Devices and methods for the restoration of a spinal disc |
| 02/23/2006 | WO2006020996A2 Treatment of parkinson's disease and related disorders |
| 02/23/2006 | WO2006020949A2 Combined gene therapy for the treatment of macroscopic gliomas |
| 02/23/2006 | WO2006020768A2 Chemically modified oligonucleotides |
| 02/23/2006 | WO2006020480A2 Adenoviral vector compositions |
| 02/23/2006 | WO2006019037A1 Method of judging liver fibrosis stage |
| 02/23/2006 | WO2006018836A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 02/23/2006 | WO2005111069A3 Morphogenic proteins and stimulatory factors in gene therapy |
| 02/23/2006 | WO2005107816A3 Methods and compositions for reducing viral genome amounts in a target cell |
| 02/23/2006 | WO2005061538A3 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its uses for the treatment of angiogenic-related disorders |
| 02/23/2006 | WO2004071458A3 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS |
| 02/23/2006 | WO2004043406A3 ENGINEERED RNAi ADENOVIRUS SILENCING EXPRESSION (ERASE) OF DNA REPAIR PROTEINS |
| 02/23/2006 | WO2003089453A3 INHIBITION OF Ii EXPRESSION IN MAMMALIAN CELLS |
| 02/23/2006 | WO2003072732A3 Methods of making hypermutable cells using pmsr homologs |
| 02/23/2006 | US20060040886 heat shock protein 27 inhibitors; RNA interference; nuclease resistance |
| 02/23/2006 | US20060040885 Bioprosthetic heart valves |
| 02/23/2006 | US20060040884 Antisense oligonucleotides directed to genes regulated by trapoxin-induced HDAC inhibition |
| 02/23/2006 | US20060040883 Methods for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA |
| 02/23/2006 | US20060040882 Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells |
| 02/23/2006 | US20060040881 Modulators of coagulation factors |
| 02/23/2006 | US20060040880 Methods and compositions for treating neuropathic pain |
| 02/23/2006 | US20060040879 Chloroquine coupled nucleic acids and methods for their synthesis |
| 02/23/2006 | US20060040878 Bacterial antigen induced bone morphogenesis |
| 02/23/2006 | US20060040861 Method of treating, preventing, and diagnosing prostate cancer |
| 02/23/2006 | US20060040853 Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras |
| 02/23/2006 | US20060040391 RNA interference vectors |
| 02/23/2006 | US20060040387 Islet cells from human embryonic stem cells |
| 02/23/2006 | US20060040360 Adipocyte complement related protein homolog zacrp7 |
| 02/23/2006 | US20060040357 Novel nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor |
| 02/23/2006 | US20060040347 Use of triplex structure DNA in transferring nucleotide sequences |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 02/23/2006 | US20060040290 Methods, compositions, and kits comprising PNA for RNA interference |
| 02/23/2006 | US20060040266 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 02/23/2006 | US20060040265 Regulation of novel human asparagine-hydroxylases |
| 02/23/2006 | US20060040253 Use of Smad3 inhibitor in the treatment of fibrosis dependent on epithelial to mesenchymal transition as in the eye and kidney |
| 02/23/2006 | US20060039962 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/23/2006 | US20060039928 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/23/2006 | US20060039921 Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | US20060039915 P-cadherin as a target for anti-cancer therapy |
| 02/23/2006 | US20060039910 Methods and compositions for treating allergic inflammation |
| 02/23/2006 | US20060039897 transforming a stinging cell or stinging cell progenitor with a polynucleotide encoding a therapeutic, cosmetic or diagnostic agent to thereby generate at least one stinging cell expressing therapeutic, cosmetic or diagnostic agent in the stinging cell (derived from Cnidaria, Dinoflagelleaa) |
| 02/23/2006 | US20060039893 Expression vector includes insert of dna which codes for exogenous protein and adenovirus dna having deletion from nucleotides 356-4020; production of recombinant proteins; gene therapy against tumors and cancer |